These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 947647)

  • 1. Primary immune response to Helix pomatia haemocyanin in malignant melanoma. Relationship between 19S and 7S antibody response and in vitro lymphocyte transformation.
    Gast GC; The TH; Schraffordt Koops H; Snijder AM; Huiges HA
    Clin Exp Immunol; 1976 Mar; 23(3):491-8. PubMed ID: 947647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune response in asymptomatic paraproteinemia. I. Primary and secondary antibody response to Helix pomatia hemocyanin.
    Weits J; de Gast GC; The TH; Marrink J; Mandema E
    Scand J Immunol; 1976; 5(10):1163-71. PubMed ID: 1013650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Class-specific antibody titres (ELISA) against the primary immunogen Helix pomatia haemocyanin (HPH) in man.
    Weits J; de Gast GC; The TH; Esselink MT; Deelder AM; Petrovic M; Mandema E
    Clin Exp Immunol; 1978 Jun; 32(3):443-50. PubMed ID: 80296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The primary immune response in patients with selective IgA deficiency.
    De Graeff PA; The TH; van Munster PJ; Out TA; Vossen JM; Zegers BJ
    Clin Exp Immunol; 1983 Dec; 54(3):778-84. PubMed ID: 6652975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The primary immune response of patients with different stages of squamous-cell bronchial carcinoma.
    Jansen HM; The TH; de Gast GC; Esselink MT; Pastoor G; Orie NG
    Thorax; 1978 Dec; 33(6):755-60. PubMed ID: 746500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class- and subclass-specific antibody response to hemocyanin in nonmalignant paraproteinemia.
    Weits J; de Gast GC; The TH; Esselink MT; van der Giessen M; Mandema E
    J Lab Clin Med; 1979 Sep; 94(3):458-66. PubMed ID: 469381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody responses in vivo in chromosome instability syndromes with immunodeficiency.
    Weemaes CM; The TH; van Munster PJ; Bakkeren JA
    Clin Exp Immunol; 1984 Sep; 57(3):529-34. PubMed ID: 6467678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro lymphocyte reactivity and T cell levels in patients with melanoma: correlations with clinical and pathological stage.
    Silverman NA; Alexander JC; Potvin C; Chretien PB
    Surgery; 1976 Mar; 79(3):332-9. PubMed ID: 1083075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immune profil in melanoma patients. III. Behavior of immunglobulins (IgG, IgA, IgM) and of whole complement in serum at the beginning and during BCG-therapy (author's transl)].
    Knopf B; Wätzig V; Stelzner A
    Arch Geschwulstforsch; 1979; 49(4):299-304. PubMed ID: 496567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study of lymphocyte responses to phytohemagglutinin in melanoma patients. (lack o prognostic value of correlation with minimal tumor burden).
    Kovarík J; Ninger E; Zemanová D; Lauerová L
    Neoplasma; 1980; 27(5):575-82. PubMed ID: 7231613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The primary immune response in bronchial asthma. I. A kinetic study of Helix pomatia hemocyanin-specific IgE, IgG, IgA, and IgM antibody responses in patients with asthma and in matched controls.
    Weller FR; Kallenberg CG; Jansen HM; Torensma R; Klaassen RJ; Weller HH; Orie NG; The TH
    J Allergy Clin Immunol; 1985 Jul; 76(1):29-34. PubMed ID: 4008812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cell activity in systemic lupus erythematosus: depressed in vivo humoral immune response to a primary antigen (haemocyanin) and increased in vitro spontaneous immunoglobulin synthesis.
    Kallenberg CG; Limburg PC; Van Slochteren C; Van der Woude FJ; The TH
    Clin Exp Immunol; 1983 Aug; 53(2):371-83. PubMed ID: 6192955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of antibodies against GM2 ganglioside by immunizing melanoma patients using GM2-keyhole limpet hemocyanin + QS21 vaccine: a dose-response study.
    Chapman PB; Morrissey DM; Panageas KS; Hamilton WB; Zhan C; Destro AN; Williams L; Israel RJ; Livingston PO
    Clin Cancer Res; 2000 Mar; 6(3):874-9. PubMed ID: 10741710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody responses in melanoma patients immunized with an anti-idiotype antibody mimicking disialoganglioside GD2.
    Foon KA; Sen G; Hutchins L; Kashala OL; Baral R; Banerjee M; Chakraborty M; Garrison J; Reisfeld RA; Bhattacharya-Chatterjee M
    Clin Cancer Res; 1998 May; 4(5):1117-24. PubMed ID: 9607568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Secretion of immunoglobulins in malignant melanoma of the skin].
    Babakova SV; Kuznetsov VA; Gorodilova VV; Konradov AA; Chervonnaia LV
    Vopr Onkol; 1988; 34(3):314-8. PubMed ID: 3358294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis.
    Cambridge G; Leandro MJ; Edwards JC; Ehrenstein MR; Salden M; Bodman-Smith M; Webster AD
    Arthritis Rheum; 2003 Aug; 48(8):2146-54. PubMed ID: 12905467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral immune response to intralymphatic immunotherapy for disseminated melanoma: correlation with clinical response.
    Ahn SS; Irie RF; Weisenburger TH; Jones PC; Juillard G; Roe DJ; Morton DL
    Surgery; 1982 Aug; 92(2):362-7. PubMed ID: 7101129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous immune response to early- and intermediate-stage melanoma is correlated with outcomes and is independent of locoregional relapse and standard prognostic factors.
    Litvak DA; Gupta RK; Yee R; Wanek LA; Ye W; Morton DL
    J Am Coll Surg; 2004 Jan; 198(1):27-35. PubMed ID: 14698308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral and cell-mediated immune response in patients with malignant melanoma. I. In vitro lymphocyte reactivity to PHA and antigens following immunization.
    de Gast GC; The TH; Schraffordt Koops H; Huiges HA; Oldhoff J; Nieweg HO
    Cancer; 1975 Oct; 36(4):1289-97. PubMed ID: 1175127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary cell-mediated immune response in bronchial asthma. Relationship between primary in vitro and in vivo cell-mediated and antibody responses in patients with asthma and healthy controls.
    Weller FR; Kallenberg CG; Orie NG; Weller HH; Jansen HM; The TH
    Clin Allergy; 1986 May; 16(3):241-50. PubMed ID: 3719936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.